99
Participants
Start Date
December 31, 2006
Primary Completion Date
July 31, 2008
Study Completion Date
September 30, 2008
Palifermin
Keratinocyte growth factor administered via injection
Palifermin placebo
Keratinocyte growth factor placebo administered via injection
NY Univ. HIV/AIDS CRS, New York
Trillium Health ACTG CRS, Rochester
Univ. of Rochester ACTG CRS, Rochester
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
IHV Baltimore Treatment CRS, Baltimore
Unc Aids Crs, Chapel Hill
Duke Univ. Med. Ctr. Adult CRS, Durham
The Ponce de Leon Ctr. CRS, Atlanta
Vanderbilt Therapeutics CRS, Nashville
The Ohio State University Medical Center, Columbus
Case CRS, Cleveland
MetroHealth CRS, Cleveland
USC CRS, Los Angeles
UCLA CARE Center CRS, Los Angeles
Harbor-UCLA Med. Ctr. CRS, Torrance
Ucsd, Avrc Crs, San Diego
Stanford CRS, Palo Alto
University of Washington AIDS CRS, Seattle
Univ. of Miami AIDS CRS, Miami
Bmc Actg Crs, Boston
Washington U CRS, St Louis
Columbia P&S CRS, New York
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH